Cassava Sciences | PTIE - Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
Abbott USD 299M 231M 2026-06
Amgen USD 95.64B 94.98B 2026-06
Biogen USD 72.6M 12.6M 2025-06
Cara Therapeutics -89.64M 128.67M 2025-12
Cassava Sciences USD 108.37M 396.06M 2026-03
Eisai JPY 1.96B 409M 2026-06
Eli Lilly USD 114.7M 134.3M 2025-09
Geron USD 7.15M 150K 2026-03
J&J USD 43M 25M 2026-03
Merck USD 525M 46M 2026-06
Novartis USD 462M 119M 2026-06
Novavax USD 5.82M 342K 2025-12
Pfizer USD 667M 4M 2026-06
Roche Holding CHF 304M 7.5M 2025-06